Skip Navigation



Rheumatology Advance Access published online on February 16, 2008

Rheumatology, doi:10.1093/rheumatology/ken023
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
47/4/484    most recent
ken023v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kümpers, P.
Right arrow Articles by Haubitz, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kümpers, P.
Right arrow Articles by Haubitz, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Serum leptin and ghrelin correlate with disease activity in ANCA-associated vasculitis

P. Kümpers1, R. Horn2, G. Brabant3, A. Woywodt1, M. Schiffer1, H. Haller1 and M. Haubitz1

1Department of Nephrology, 2Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany and 3Department of Endocrinology, Christie Hospital, Manchester, UK.

Correspondence to: P. Kümpers, Department of Nephrology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. E-mail: kuempers.philipp{at}mh-hannover.de; pkuempers{at}htp-tel.de


   Abstract

Objectives. To study serum levels of leptin and ghrelin in ANCA-associated vasculitis (AAV).

Methods. Thirty-seven patients with AAV (21 patients with active AAV at initial presentation and during follow-up, 16 patients with AAV in long-term remission) and 21 matched healthy controls were included. Serum levels of leptin and ghrelin were measured at 0, 6 and 12 months by radioimmunoassay. Disease activity was gauged by Birmingham Vasculitis Activity Score (BVAS), CRP and circulating endothelial cells (CECs).

Results. Leptin levels were significantly lower in patients than in healthy controls (9.1 ± 6.1 vs 22.3 ± 22.4 ng/ml; P < 0.05). The difference persisted when corrected for BMI. Leptin levels increased significantly after 6 (27.8 ± 21.9 ng/ml; P < 0.001) and 12 months (24.6 ± 21.0 ng/ml; P < 0.001). Ghrelin levels were significantly elevated in patients compared with controls (402.6 ± 112.9 vs 294.8 ± 70.9 pmol/l; P < 0.005) and declined to normal values at 12 months (306.4 ± 36.2 pmol/l). There was a significant positive correlation between ghrelin levels and disease activity, whereas leptin levels were negatively correlated with disease activity (CRP, BVAS and CECs). Accordingly, correlations between the ghrelin/leptin ratio and markers of disease activity reached the highest level of significance (all P < 0.001).

Conclusions. Active AAV is characterized by decreased serum leptin and increased serum ghrelin, both of which return to normal with successful therapy. The role of leptin and ghrelin during the pathogenesis of AAV and the effects of these peptides on endothelial cells warrant further study.

KEY WORDS: ANCA-associated vasculitis, Leptin, Ghrelin, Circulating endothelial cells

Submitted 23 May 2007; revised version accepted 10 January 2008.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
M. Thewissen and J. W. Cohen Tervaert
Leptin and ANCA-associated vasculitis: a healthy link?
Rheumatology, April 1, 2008; 47(4): 387 - 389.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.